Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Short-term acute careGovernment (local)Major teachingEmergency servicesUniversity of California Health

Uci Health-Orange

101 City Drive South, Orange, CA, 92868 · (714) 456-7890

$2.54B

Net patient revenue, FY 2025

Beds

911

FY 2025

Star rating

4 of 5

Patient survey: 2 of 5

Net patient revenue

$2.54B

FY 2025

Net income

-$155.7M

Patient care margin -6.1%

Discharges

30,155

Occupancy 92.1%

Clinicians

2,627

Medicare clinicians who work here

Finances and location

Yearly cost reports (fiscal years as the hospital reports them) and where the hospital is

Revenue and expenses by fiscal year

Net patient revenueOperating expenses

4 hospitals in the system. Zoom, drag, or use the buttons.

Loading map...
This hospital3 other hospitals of the systemPins are at the street address.

Financials by fiscal year

US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.

Fiscal yearNet patient revenueOperating expensesPatient care marginNet incomeDischargesUncompensated careMedicare daysMedicaid days
2025$2.54B$2.70B-6.1%-$155.7M30,155$29.1M20.8%5.8%
2024$2.09B$2.26B-8.2%-$1.5M24,056$46.7M20.4%8.2%
2023$1.90B$1.94B-2.5%$131.2M22,163$45.2M19.3%-
2022$1.66B$1.76B-6.2%$28.7M22,651$29.7M20.2%19.2%
2021$1.47B$1.56B-6.5%$155.1M20,675$38.4M19.4%15.3%
2020$1.30B$1.51B-15.8%-$56.5M19,931$37.0M19.2%18.7%

Quality of care

Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.

Death rates

Death rate after heart bypass surgery3.3%US median 2.3%
Death rate for COPD patients7.2%US median 8.5%
Death rate for heart attack patients12.2%US median 11.8%
Death rate for heart failure patients10.3%US median 11%
Hospital-wide death rate within 30 days3%US median 3.9%
Death rate for pneumonia patients15.1%US median 15.2%
Death rate for stroke patients10.4%US median 11.6%

Readmissions

Readmission rate after heart bypass surgery12.9%US median 10.9%
Readmission rate for COPD21%US median 19.8%
Readmission rate after a heart attack14.6%US median 14.4%
Readmission rate for heart failure20.8%US median 21.3%
Readmission rate after hip or knee replacement5.8%US median 5.8%
Readmission rate for pneumonia16.8%US median 17.2%

Patient safety

Complications after hip or knee replacement3.5%US median 4.1%
Serious complications (patient safety composite)0.90US median 0.96

Infections

C. diff intestinal infections (ratio to expected)0.55US median 0.28 · better
Central line bloodstream infections (ratio to expected)0.56US median 0.48 · better
Surgical site infections after colon surgery (ratio to expected)0.45US median 0.72 · better
Surgical site infections after hysterectomy (ratio to expected)0.55US median 0.81
MRSA bloodstream infections (ratio to expected)0.36US median 0.60 · better
Catheter urinary tract infections (ratio to expected)0.42US median 0.40 · better

Patient survey

Doctors always communicated well74%US median 79%
Nurses always communicated well72%US median 80%
Patient survey summary star rating2 of 5US median 3 of 5
Area around the room always quiet at night40%US median 59%
Patients who rated the hospital 9 or 10 out of 1065%US median 72%
Room and bathroom always clean62%US median 73%
Patients who would definitely recommend the hospital67%US median 71%

Timely and effective care

Patients who left the emergency department before being seen2%US median 1%
Median time in the emergency department before leaving (minutes)318 minUS median 148 min
Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge16%US median 15%
Patients who got appropriate care for severe sepsis and septic shock66%US median 65%
Healthcare workers given the flu vaccine74%US median 79%

Hospital profile

Medicare certification number (CCN)
050348
Organization NPI
1689608150
Legal name
University of California Irvine
County
Orange County, CA
Ownership
Government (local)
Teaching
Major teaching
In Medicare since
1976
Full-time employees
7,584

Clinicians who work here

Medicare clinicians who list this hospital, by specialty

Specialties

Find doctors and clinicians

Other University of California Health hospitals

All 4

Other hospitals in Orange

All California hospitals

Similar short-term acute care hospitals in California

Closest in number of beds

HospitalPlaceBeds
Cedars-Sinai Medical CenterLos Angeles, CA913
UCSF Medical CenterSan Francisco, CA887
Community Regional Medical CenterFresno, CA783
Santa Clara Valley Medical CenterSan Jose, CA1,060
Sharp Memorial HospitalSan Diego, CA745
Stanford Health CareStanford, CA717

Medicare hospital stays

Inpatient stays by diagnosis related group (DRG), 2024

Diagnosis groupStaysAverage chargeMedicare pays per stayAll hospitals
DRG 871 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC423$131,658.86$27,059.05$15,524.21
DRG 291 HEART FAILURE AND SHOCK WITH MCC137$96,845.31$17,915.49$10,022.34
DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC89$61,536.63$13,772.80$7,681.44
DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC86$96,209.66$18,591.94$10,642.23
DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC73$115,370.44$24,262.42$14,289.25
DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC62$93,225.65$21,729.79$13,076.55
DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC57$111,870.51$20,786.56$12,667.88
DRG 266 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITH MCC55$226,822.82$86,551.04$52,994.82
DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC54$454,389.46$90,024.06$40,556.82
DRG 274 PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITHOUT MCC52$144,347.46$42,214.04$24,748.54
DRG 330 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC52$149,601.44$30,649.58$18,026.21
DRG 025 CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MCC50$402,677.14$76,360.98$37,824.45
DRG 064 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC49$119,311.45$23,597.55$15,695.20
DRG 267 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITHOUT MCC46$180,573.65$66,893.26$40,566.75
DRG 682 RENAL FAILURE WITH MCC45$107,012.40$20,992.44$11,457.18

Medicare outpatient services

Hospital outpatient services by payment group (APC), 2024

Service groupServicesPatientsMedicare pays per serviceAll hospitals
APC 5491 Level 1 Intraocular Procedures1,6281,017$2,275.70$1,751.67
APC 5372 Level 2 Urology and Related Services815477$636.98$502.15
APC 8011 Comprehensive Observation Services800744$2,667.41$2,090.36
APC 5302 Level 2 Upper GI Procedures661589$1,859.50$1,444.50
APC 5373 Level 3 Urology and Related Services534441$1,904.94$1,516.28
APC 5503 Level 3 Extraocular, Repair, and Plastic Eye Procedures466417$2,277.39$1,780.31
APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage427397$1,543.93$1,219.56
APC 5153 Level 3 Airway Endoscopy427269$1,456.99$1,264.08
APC 5492 Level 2 Intraocular Procedures420348$3,937.36$3,116.50
APC 5375 Level 5 Urology and Related Services310286$5,041.80$3,917.51
APC 5431 Level 1 Nerve Procedures248189$1,277.43$1,406.61
APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage237182$2,722.34$2,141.49

Payments from drug and device companies

Payments drug and device companies reported to this hospital

CompanyPaymentsAmount
Merck Sharp & Dohme LLCMRK logoMRK40$2.8M
Pfizer Inc.PFE logoPFE100$1.9M
Janssen Research & Development, LLCJNJ logoJNJ123$1.6M
AstraZeneca Pharmaceuticals LPAZN logoAZN21$1.5M
Genentech, Inc.ROG.SW logoROG.SW78$1.5M
Amgen Inc.AMGN logoAMGN25$1.1M
Abbvie Inc.ABBV logoABBV113$1.0M
AstraZeneca UK LimitedAZN logoAZN5$798K
Novo Nordisk ASNVO logoNVO7$766K
E.R. Squibb & Sons, L.L.C.BMY logoBMY13$682K

Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.

Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.

How to cite: DataPorium, “Uci Health-Orange”, https://dataporium.tech/healthcare/hospitals/050348-uci-health-orange-orange

Uci Health-Orange in Numbers

Uci Health-Orange: Beds, Owner, Finances and Quality

Uci Health-Orange is the 3rd largest of the 277 short-term acute care hospitals in California. It is a government-owned short-term acute care hospital in Orange, CA with 911 beds, part of University of California Health. It is the largest of 5 hospitals in Orange by beds. Net patient revenue grew 53% from fiscal year 2022 to 2025, to $2.5 billion. It is a major teaching hospital.

What stands out

  • It lost $155.7 million in fiscal year 2025, 6.1% of its revenue, its second loss year in a row.
  • Its death rates were better than the national rate on three measures and worse on none.
  • Its readmission rate after heart bypass surgery was 12.9%, against a national median of 10.9%.
  • On average 92% of its beds were in use in fiscal year 2025, against a median of 80% for similar California short-term acute care hospitals.

Frequently asked questions

How many years in a row has Uci Health-Orange lost money?

Uci Health-Orange reported a net loss in each of its last two full fiscal years on file: $1.5 million in 2024 and $155.7 million in 2025. Before that, it reported net income of $131.2 million in fiscal year 2023.

What are Uci Health-Orange's readmission rates?

Readmission rates at Uci Health-Orange, with the national median in brackets: after heart bypass surgery 12.9% (10.9%), for COPD 21.0% (19.8%), after a heart attack 14.6% (14.4%), for heart failure 20.8% (21.3%), after hip or knee replacement 5.8% (5.8%) and for pneumonia 16.8% (17.2%).

How does Uci Health-Orange compare with other hospitals in California?

With 911 beds, Uci Health-Orange is the 3rd largest of the 277 short-term acute care hospitals in California. Among the 15 California short-term acute care hospitals closest to it in size (523 to 1,060 beds), the median patient care margin is -0.5% (Uci Health-Orange: -6.1%) and the median star rating is 4.0 of 5 (Uci Health-Orange: 4). Its net patient revenue rose 21.8% from fiscal year 2024 to 2025, to $2.54B.

How many beds does Uci Health-Orange have?

Uci Health-Orange in Orange, CA has 911 beds (fiscal year 2025 cost report); 415 beds are certified for Medicare. It discharged 30,155 inpatients that year, with 92.1% of its beds in use on average.

Is Uci Health-Orange profitable?

In fiscal year 2025 (ending 2025-06-30), Uci Health-Orange reported net patient revenue of $2.54B and operating expenses of $2.70B, a margin on patient care of -6.1%. After other income and expenses its net income was -$155.7M (-6.1% of revenue), so it lost money that year.

What health system owns Uci Health-Orange?

Uci Health-Orange is part of University of California Health, a health system with 4 hospitals based in Oakland, CA. It is a government-owned hospital.

What is Uci Health-Orange's star rating?

Uci Health-Orange has an overall rating of 4 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey. 3 death rate measures are better than the national rate and none worse.

Does Uci Health-Orange have an emergency room?

Yes, Uci Health-Orange provides emergency services.

How many doctors work at Uci Health-Orange?

2,627 Medicare clinicians list Uci Health-Orange as a hospital they work at, most often in Internal Medicine, Diagnostic Radiology, Nurse Practitioner.

What are the most common Medicare hospital stays at Uci Health-Orange?

In 2024, Uci Health-Orange had 3,680 Medicare inpatient stays in 126 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 423 stays; Medicare paid $27,059.05 per stay on average, compared with $15,524.21 across all hospitals.

How much did drug and device companies pay Uci Health-Orange?

In 2025, drug and device companies reported $23.0M in payments to Uci Health-Orange ($2.4M general and $20.6M for research) from 143 companies.

LinkedInLinkedInXXYouTubeYouTube